Concise review: Androgen receptor differential roles in stem/progenitor cells including prostate, embryonic, stromal, and hematopoietic lineages

Stem Cells

Volumn 32, Issue 9, 2014, Pages 2299-2308

  Huang, Chiung Kuei ^a   Luo, Jie ^a   Lee, Soo Ok ^a   Chang, Chawnshang ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Adult stem cells; Androgen; Androgen receptor; Prostate cancer; Prostate cancer stem cells; Stem cells

Indexed keywords

ANDROGEN RECEPTOR;

ADIPOGENESIS; APOPTOSIS; B LYMPHOCYTE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL DEATH; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; CELL RENEWAL; EMBRYO; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; LIVER FIBROSIS; METASTASIS; NEUTROPHIL; OXIDATIVE STRESS; PROSTATE CANCER; PROSTATE STEM CELL; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; STROMA CELL; STROMAL STEM CELL; T LYMPHOCYTE; ANIMAL; CELL LINEAGE; CYTOLOGY; EPITHELIUM CELL; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; PROSTATE;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; EMBRYONIC STEM CELLS; EPITHELIAL CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; PROSTATE; RECEPTORS, ANDROGEN; STEM CELLS;

EID: 84906258431     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1722     Document Type: Review

References (100)

1. Becker AJ, Mc CE, Till JE,. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 1963; 197: 452-454.
2. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
3. Li L, Clevers H,. Coexistence of quiescent and active adult stem cells in mammals. Science 2010; 327: 542-545.
4. Patrawala L, Calhoun T, Schneider-Broussard R, et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006; 25: 1696-1708.
5. Goldstein AS, Huang J, Guo C, et al. Identification of a cell of origin for human prostate cancer. Science 2010; 329: 568-571.
6. Lobo NA, Shimono Y, Qian D, et al. The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007; 23: 675-699.
7. Yeh S, Tsai MY, Xu Q, et al. Generation and characterization of androgen receptor knockout (ARKO) mice: An in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA 2002; 99: 13498-13503.
8. Heinlein CA, Chang C,. Androgen receptor (AR) coregulators: An overview. Endocr Rev 2002; 23: 175-200.
9. Huang CK, Lai KP, Luo J, et al. Loss of androgen receptor promotes adipogenesis but suppresses osteogenesis in bone marrow stromal cells. Stem Cell Res 2013; 11: 938-950.
10. Altuwaijri S, Chuang KH, Lai KP, et al. Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells. Mol Endocrinol 2009; 23: 444-453.
11. Huang CK, Lee SO, Lai KP, et al. Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis. Hepatology 2013; 57: 1550-1563.
12. Chuang KH, Altuwaijri S, Li G, et al. Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor. J Exp Med 2009; 206: 1181-1199.
13. Lai KP, Lai JJ, Chang P, et al. Targeting thymic epithelia AR enhances T-cell reconstitution and bone marrow transplant grafting efficacy. Mol Endocrinol 2013; 27: 25-37.
14. Rajender S, Singh L, Thangaraj K,. Phenotypic heterogeneity of mutations in androgen receptor gene. Asian J Androl 2007; 9: 147-179.
15. Yu Z, Dadgar N, Albertelli M, et al. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest 2006; 116: 2663-2672.
16. Niu Y, Chang TM, Yeh S, et al. Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails. Oncogene 2010; 29: 3593-3604.
17. Tian J, Lee SO, Liang L, et al. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis. J Biol Chem 2012; 287: 39954-39966.
18. Huang CK, Tsai MY, Luo J, et al. Suppression of androgen receptor enhances the self-renewal of mesenchymal stem cells through elevated expression of EGFR. Biochim Biophys Acta 2013; 1833: 1222-1234.
19. Lee SO, Ma Z, Yeh CR, et al,. New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells. J Mol Cell Biol 2013; 5: 14-26.
20. Chang CY, Hsuuw YD, Huang FJ, et al. Androgenic and antiandrogenic effects and expression of androgen receptor in mouse embryonic stem cells. Fertil Steril 2006; 85 (suppl 1): 1195-1203.
21. Sir-Petermann T, Maliqueo M, Angel B, et al. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: Possible implications in prenatal androgenization. Hum Reprod 2002; 17: 2573-2579.
22. Sauter CN, McDermid RL, Weinberg AL, et al. Differentiation of murine embryonic stem cells induces progesterone receptor gene expression. Exp Cell Res 2005; 311: 251-264.
23. Goldman-Johnson DR, de Kretser DM, Morrison JR,. Evidence that androgens regulate early developmental events, prior to sexual differentiation. Endocrinology 2008; 149: 5-14.
24. West FD, Henderson WM, Yu P, et al. Metabolomic response of human embryonic stem cell-derived germ-like cells after exposure to steroid hormones. Toxicol Sci 2012; 129: 9-20.
25. Baker MA, Aitken RJ,. Reactive oxygen species in spermatozoa: Methods for monitoring and significance for the origins of genetic disease and infertility. Reprod Biol Endocrinol 2005; 3: 67.
26. Lee MN, Lee SH, Lee MY, et al. Effect of dihydrotestosterone on mouse embryonic stem cells exposed to H2O2-induced oxidative stress. J Vet Sci 2008; 9: 247-256.
27. Lee SH, Heo JS, Lee MY, et al. Effect of dihydrotestosterone on hydrogen peroxide-induced apoptosis of mouse embryonic stem cells. J Cell Physiol 2008; 216: 269-275.
28. Thomson M, Liu SJ, Zou LN, et al. Pluripotency factors in embryonic stem cells regulate differentiation into germ layers. Cell 2011; 145: 875-889.
29. Lai KP, Yamashita S, Huang CK, et al. Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines. EMBO Mol Med 2012; 4: 791-807.
30. Titus MA, Schell MJ, Lih FB, et al. Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Clin Cancer Res 2005; 11: 4653-4657.
31. Lai KP, Huang CK, Chang YJ, et al. New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells. Am J Pathol 2013; 182: 460-473.
32. Bianchini D, Lorente D, Rodriguez-Vida A, et al. Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone. Eur J Cancer 2014; 50: 78-84.
33. Lee SO, Tian J, Huang CK, et al. Suppressor role of androgen receptor in proliferation of prostate basal epithelial and progenitor cells. J Endocrinol 2012; 213: 173-182.
34. Grisanzio C, Signoretti S,. p63 in prostate biology and pathology. J Cell Biochem 2008; 103: 1354-1368.
35. Isaacs JT,. Prostate stem cells and benign prostatic hyperplasia. Prostate 2008; 68: 1025-1034.
36. Wang X, Kruithof-de Julio M, Economides KD, et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 2009; 461: 495-500.
37. Richardson GD, Robson CN, Lang SH, et al. CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 2004; 117: 3539-3545.
38. Lawson DA, Xin L, Lukacs RU, et al. Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci USA 2007; 104: 181-186.
39. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, et al. Hierarchical organization of prostate cancer cells in xenograft tumors: The CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res 2007; 67: 6796-6805.
40. Xin L, Lawson DA, Witte ON,. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 2005; 102: 6942-6947.
41. Schroeder A, Herrmann A, Cherryholmes G, et al. Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling. Cancer Res 2014; 74: 1227-1237.
42. Qin J, Liu X, Laffin B, et al. The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell 2012; 10: 556-569.
43. Seiler D, Zheng J, Liu G, et al. Enrichment of putative prostate cancer stem cells after androgen deprivation: Upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines. Prostate 2013; 73: 1378-1390.
44. Niu Y, Altuwaijri S, Yeh S, et al. Targeting the stromal androgen receptor in primary prostate tumors at earlier stages. Proc Natl Acad Sci USA 2008; 105: 12188-12193.
45. Li H, Chen X, Calhoun-Davis T, et al. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res 2008; 68: 1820-1825.
46. Bisson I, Prowse DM,. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Cell Res 2009; 19: 683-697.
47. Dubrovska A, Kim S, Salamone RJ, et al. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA 2009; 106: 268-273.
48. Linn DE, Yang X, Sun F, et al. A role for OCT4 in tumor initiation of drug-resistant prostate cancer cells. Genes Cancer 2010; 1: 908-916.
49. Jeter CR, Badeaux M, Choy G, et al. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 2009; 27: 993-1005.
50. Kregel S, Kiriluk KJ, Rosen AM, et al. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer. PLoS One 2013; 8: e53701.
51. Baccelli I, Trumpp A,. The evolving concept of cancer and metastasis stem cells. J Cell Biol 2012; 198: 281-293.
52. Gao D, Vahdat LT, Wong S, et al. Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Res 2012; 72: 4883-4889.
53. Niu Y, Altuwaijri S, Lai KP, et al. Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl Acad Sci USA 2008; 105: 12182-12187.
54. Luo J, Ok Lee S, Liang L, et al. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling. Oncogene 2013. Jun 24. doi: 10.1038/onc.2013.233. [Epub ahead of print].
55. Sun Y, Wang BE, Leong KG, et al. Androgen deprivation causes epithelial-mesenchymal transition in the prostate: Implications for androgen-deprivation therapy. Cancer Res 2012; 72: 527-536.
56. Lin TH, Lee SO, Niu Y, et al. Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9(R) lead to promotion versus suppression of prostate cancer metastasis. J Biol Chem 2013; 288: 19359-19369.
57. Epis MR, Giles KM, Barker A, et al. miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer. J Biol Chem 2009; 284: 24696-24704.
58. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309-313.
59. Terai S, Ishikawa T, Omori K, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006; 24: 2292-2298.
60. Stamm C, Westphal B, Kleine HD, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 361: 45-46.
61. Burt RK, Loh Y, Pearce W, et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 2008; 299: 925-936.
62. Houlihan DD, Newsome PN,. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 2008; 135: 438-450.
63. Crisostomo PR, Wang M, Herring CM, et al. Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: Role of the 55 kDa TNF receptor (TNFR1). J Mol Cell Cardiol 2007; 42: 142-149.
64. Semirale AA, Zhang XW, Wiren KM,. Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation. J Cell Biochem 2011; 112: 1773-1786.
65. Dexheimer V, Mueller S, Braatz F, et al. Reduced reactivation from dormancy but maintained lineage choice of human mesenchymal stem cells with donor age. PLoS One 2011; 6: e22980.
66. Fossett E, Khan WS,. Optimising human mesenchymal stem cell numbers for clinical application: A literature review. Stem Cells Int 2012; 2012: 465259.
67. Yeung DK, Griffith JF, Antonio GE, et al. Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: A proton MR spectroscopy study. J Magn Reson Imaging 2005; 22: 279-285.
68. Wang X, Li F, Niyibizi C,. Progenitors systemically transplanted into neonatal mice localize to areas of active bone formation in vivo: Implications of cell therapy for skeletal diseases. Stem Cells 2006; 24: 1869-1878.
69. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-705.
70. Lan L, Chen Y, Sun C, et al. Transplantation of bone marrow-derived hepatocyte stem cells transduced with adenovirus-mediated IL-10 gene reverses liver fibrosis in rats. Transpl Int 2008; 21: 581-592.
71. Alison MR, Poulsom R, Jeffery R, et al. Hepatocytes from non-hepatic adult stem cells. Nature 2000; 406: 257.
72. Tsai MY, Shyr CR, Kang HY, et al. The reduced trabecular bone mass of adult ARKO male mice results from the decreased osteogenic differentiation of bone marrow stroma cells. Biochem Biophys Res Commun 2011; 411: 477-482.
73. Kemppainen JA, Langley E, Wong CI, et al. Distinwuishing androgen receptor agonists and antagonists: Distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. Mol Endocrinol 1999; 13: 440-454.
74. Jasuja R, Catlin DH, Miller A, et al. Tetrahydrogestrinone is an androgenic steroid that stimulates androgen receptor-mediated, myogenic differentiation in C3H10T1/2 multipotent mesenchymal cells and promotes muscle accretion in orchidectomized male rats. Endocrinology 2005; 146: 4472-4478.
75. Jasuja R, Ramaraj P, Mac RP, et al. Delta-4-androstene-3,17-dione binds androgen receptor, promotes myogenesis in vitro, and increases serum testosterone levels, fat-free mass, and muscle strength in hypogonadal men. J Clin Endocrinol Metab 2005; 90: 855-863.
76. Singh R, Bhasin S, Braga M, et al. Regulation of myogenic differentiation by androgens: Cross talk between androgen receptor/beta-catenin and follistatin/transforming growth factor-beta signaling pathways. Endocrinology 2009; 150: 1259-1268.
77. Wang Y, Beydoun MA,. The obesity epidemic in the United States-Gender, #age, |socioeconomic, racial/ethnic, and geographic characteristics: A systematic review and meta-regression analysis. Epidemiol Rev 2007; 29: 6-28.
78. Singh R, Artaza JN, Taylor WE, et al. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: Nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 2006; 147: 141-154.
79. Singh R, Artaza JN, Taylor WE, et al. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 2003; 144: 5081-5088.
80. Dieudonne MN, Pecquery R, Leneveu MC, et al. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: Evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2. Endocrinology 2000; 141: 649-656.
81. Okita K, Ichisaka T, Yamanaka S,. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448: 313-317.
82. Toma C, Wagner WR, Bowry S, et al. Fate of culture-expanded mesenchymal stem cells in the microvasculature: In vivo observations of cell kinetics. Circ Res 2009; 104: 398-402.
83. Gallien-Lartigue O,. Differential effects of external agents on the G1-S transit rate of murine pluripotent hemopoietic stem cells (CFUs) after their release from G0. Stem Cells 1982; 2: 218-228.
84. Freedman MH, Saunders EF,. Factors affecting erythroid colony growth (CFU-E) from human marrow. Exp Hematol 1977; 5: 250-253.
85. Reissmann KR, Udupa KB, Kawada K,. Effects of erythropoietin and androgens on erythroid stem cells after their selective suppression by BCNU. Blood 1974; 44: 649-657.
86. Beckman B, Fisher JW,. Decreased erythroid colony-forming cell response of XTfm/Y mice to testosterone and 5 beta-dihydrotestosterone. Endocrinology 1980; 107: 1587-1592.
87. Neff MS, Goldberg J, Slifkin RF, et al. A comparison of androgens for anemia in patients on hemodialysis. N Engl J Med 1981; 304: 871-875.
88. Calado RT, Yewdell WT, Wilkerson KL, et al. Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood 2009; 114: 2236-2243.
89. Viselli SM, Reese KR, Fan J, et al. Androgens alter B cell development in normal male mice. Cell Immunol 1997; 182: 99-104.
90. Erben RG, Eberle J, Stangassinger M,. B lymphopoiesis is upregulated after orchiectomy and is correlated with estradiol but not testosterone serum levels in aged male rats. Horm Metab Res 2001; 33: 491-498.
91. Smithson G, Couse JF, Lubahn DB, et al. The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. J Immunol 1998; 161: 27-34.
92. Olsen NJ, Gu X, Kovacs WJ,. Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development. J Clin Invest 2001; 108: 1697-1704.
93. Henderson J,. On the relationship of the thymus to the sexual organs: The I influence of castration on the thymus. J Physiol 1904; 31: 222-229.
94. Heng TS, Goldberg GL, Gray DH, et al. Effects of castration on thymocyte development in two different models of thymic involution. J Immunol 2005; 175: 2982-2993.
95. McMurray RW, Suwannaroj S, Ndebele K, et al. Differential effects of sex steroids on T and B cells: Modulation of cell cycle phase distribution, apoptosis and bcl-2 protein levels. Pathobiology 2001; 69: 44-58.
96. Olsen NJ, Olson G, Viselli SM, et al. Androgen receptors in thymic epithelium modulate thymus size and thymocyte development. Endocrinology 2001; 142: 1278-1283.
97. Mantalaris A, Panoskaltsis N, Sakai Y, et al. Localization of androgen receptor expression in human bone marrow. J Pathol 2001; 193: 361-366.
98. Ibanez L, Jaramillo AM, Ferrer A, et al. High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: Normalization with metformin and flutamide overcomes the aggravation by oral contraception. Hum Reprod 2005; 20: 2457-2462.
99. Inamdar Doddamani LS, Jayamma Y,. Acceleration of neutrophil precursors' maturation and immunostimulation of CD3+, CD4+ lymphocytes by stanozolol in mice. J Steroid Biochem Mol Biol 2012; 129: 172-178.
100. De Gendt K, Verhoeven G,. Tissue- and cell-specific functions of the androgen receptor revealed through conditional knockout models in mice. Mol Cell Endocrinol 2012; 352: 13-25.